文献速递糖尿病肥胖与代谢综合征

长期鼻内胰岛素不影响健康男性肝脏脂质但降低循环支链氨基酸

Chronic Intranasal Insulin Does Not Affect Hepatic Lipids but Lowers Circulating BCAAs in Healthy Male Subjects.
PubMed 文献 · J Clin Endocrinol Metab · 2017-01-01

在维也纳医科大学开展随机双盲安慰剂对照试验,20名健康男性接受4周鼻内胰岛素(40 IU,每日4次)或安慰剂。结果显示鼻内胰岛素未改变体重、体质指数和肝脏脂质含量,但降低了循环支链氨基酸水平,支持脑胰岛素调控人类支链氨基酸代谢的假说。

要点

  • 4周鼻内胰岛素(40 IU,每日4次)未改变健康男性体重、体质指数和肝脏脂质含量。
  • 鼻内胰岛素降低了健康男性循环支链氨基酸水平。
  • 结果支持脑胰岛素信号调控人类支链氨基酸代谢,脑胰岛素抵抗可能部分解释胰岛素抵抗状态下的支链氨基酸升高。

核心结论

  • 长期鼻内胰岛素不影响健康男性肝脏脂质含量,但降低循环支链氨基酸水平,支持脑胰岛素调控人类支链氨基酸代谢的假说。

研究设计与样本

  • 在维也纳医科大学开展随机、双盲、安慰剂对照试验,纳入20名健康男性志愿者。

主要发现

  • 4周鼻内胰岛素治疗(40 IU,每日4次)未改变体重、体质指数和肝脏脂质含量,但降低了循环支链氨基酸水平。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Nonalcoholic fatty liver disease and elevated circulating branched-chain amino acids (BCAAs) are common characteristics of obesity and type 2 diabetes. In rodents, brain insulin signaling controls both hepatic triglyceride secretion and BCAA catabolism. Whether brain insulin signaling controls similar metabolic pathways in humans is unknown. OBJECTIVE: Here we assessed if intranasal insulin, a method to preferentially deliver insulin to the central nervous system, is able to modulate hepatic lipid content and plasma BCAAs in humans. DESIGN/SETTING: We conducted a randomized, double-blind, placebo-controlled trial at the Medical University of Vienna. PARTICIPANTS/INTERVENTION: We assessed if a chronic 4-week intranasal insulin treatment (40 IU, 4 times daily) reduces hepatic triglyceride content and circulating BCAAs in 20 healthy male volunteers. MAIN OUTCOME MEASURES: Hepatic lipid content was assessed noninvasively by 1H-magnetic resonance spectroscopy, and BCAAs were measured by gas chromatography mass spectrometry at defined time points during the study. RESULTS: Chronic intranasal insulin treatment did not alter body weight, body mass index, and hepatic lipid content but reduced circulating BCAA levels. CONCLUSIONS: These findings support the notion that brain insulin controls BCAA metabolism in humans. Thus, brain insulin resistance could account at least in part for the elevated BCAA levels observed in the insulin-resistant state.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Scherer T, Wolf P, Smajis S, et al. Chronic Intranasal Insulin Does Not Affect Hepatic Lipids but Lowers Circulating BCAAs in Healthy Male Subjects. J Clin Endocrinol Metab. 2017. PMID: 28323986. doi:10.1210/jc.2016-3623

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。